Naber 2000b.
| Methods | Randomised, double‐blind, double‐dummy, placebo‐controlled Multicentre study: 84 North American centres | |
| Participants | Number: 688 women Age: 16‐65 years Inclusion criteria: symptomatic UAC | |
| Interventions | GROUP 1
3 days gemifloxacin (320 mg once daily) GROUP 2 3 days ciprofloxacin (250 mg twice daily) |
|
| Outcomes | Bacteriological response | |
| Notes | ||
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Allocation concealment? | Low risk | A ‐ Adequate |